{"Q": 1, "answer": "no", "rationale": "The segment describes uncertainty about manufacturing capacity, but does not use an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19072", "batch_size": 200, "batch_pos": 85, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral verbs like 'tell' and 'said' without high-potency framing.", "method": "llm_batch", "batch_id": "batch_2_12384", "batch_size": 200, "batch_pos": 22, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The verbs are plain or future tense, not describing realised impact.", "method": "llm_batch", "batch_id": "batch_3_18536", "batch_size": 200, "batch_pos": 172, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_17468", "batch_size": 200, "batch_pos": 161, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports uncertainty about manufacturing scale without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_16504", "batch_size": 200, "batch_pos": 158, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_4856", "batch_size": 200, "batch_pos": 115, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_12552", "batch_size": 200, "batch_pos": 100, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "States a limitation regarding a capability ('too early to tell how many doses... will be able to manufacture') without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_16024", "batch_size": 200, "batch_pos": 79, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
